Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01010126
Recruitment Status : Completed
First Posted : November 9, 2009
Last Update Posted : July 11, 2017
Information provided by (Responsible Party):
National Cancer Institute (NCI)